drugset / Trial / NCT01401933
Effect of Rifampin on the Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors
Non-randomizedParallel-groupOpen-labelBasic science
Summary
This is a phase 1, open-label study designed to determine the interaction of rifampin with linifanib.
Timeline
- Start
- 2011-05
- Primary completion
- 2011-10
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABT-869 | Unknown | — | — |
| Subject | Rifampin | Small molecule | — | — |